The switch from HIV latency to active replication in CD4+ T cell, which results in the manifestation of AIDS, requires the function of the two viral regulatory gene products, tatIII and art. In addition, the HIV-LTR promoter has sequences specific for ubiquitous, and possibly T cell-specific, cellular factor. An understanding of tatIII and art mechanisms of action and the interaction between viral regulatory proteins and cellular factors is crucial to the design of effective therapeutic agents. AIDS patients are often afflicted with progressive degeneration of the central nervous system that mimics the low productive, persistent, in vitro infection of human glial cells. This type of infection appears to ne different from the T-cell infection. Design of effective inhibitors for the viral replication in neural cells requires knowledge of the viral pathogenesis and regulation of viral gene expression in these cells. Members of this consortium propose to: 1) study the mechanism of action of the tatIII gene product; 2) study the mechanism of action of the art gene product; 3) study regulatory elements in the HIV-LTR promoter that interact with ubiquitous and T cell-specific cellular factors and characterize the interaction of these factors with the tatIII gene product; 4) identify and purify cellular factors which might be required for tatIII or art activity 5) study the regulation of HIV expression and pathogenesis in neural cells; 6) determine the physical structure of the tatIII and the art proteins; 7) develop cell-free, in vitro assays for tatIII and art function; 8) develop a high-capacity, cell-free assay to identify antagonists of tatIII and art function; 9) carry out a rational drug design program; and, lO) compare antagonists of tatIII or art function in HIV-infected hematopoietic vs. neural cells. The Core Facility will serve this consortium by screening for tatIII/art inhibitors, providing team members with inhibitors and reagents, and developing for clinical evaluation in AIDS patients promising drug candidates.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01AI027397-05S1
Application #
3547241
Study Section
Special Emphasis Panel (SRC (34))
Project Start
1988-09-30
Project End
1993-11-30
Budget Start
1992-09-01
Budget End
1993-11-30
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Hoffmann-LA Roche, Inc.
Department
Type
DUNS #
City
Nutley
State
NJ
Country
United States
Zip Code
07110
Parada, C A; Yoon, J B; Roeder, R G (1995) A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro. J Biol Chem 270:2274-83
Hisatake, K; Ohta, T; Takada, R et al. (1995) Evolutionary conservation of human TATA-binding-polypeptide-associated factors TAFII31 and TAFII80 and interactions of TAFII80 with other TAFs and with general transcription factors. Proc Natl Acad Sci U S A 92:8195-9
Kretzschmar, M; Stelzer, G; Roeder, R G et al. (1994) RNA polymerase II cofactor PC2 facilitates activation of transcription by GAL4-AH in vitro. Mol Cell Biol 14:3927-37
Lagna, G; Kovelman, R; Sukegawa, J et al. (1994) Cloning and characterization of an evolutionarily divergent DNA-binding subunit of mammalian TFIIIC. Mol Cell Biol 14:3053-64
Yoon, J B; Li, G; Roeder, R G (1994) Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitro. Mol Cell Biol 14:1776-85
Kim, T K; Roeder, R G (1994) Proline-rich activator CTF1 targets the TFIIB assembly step during transcriptional activation. Proc Natl Acad Sci U S A 91:4170-4
Kokubo, T; Yamashita, S; Horikoshi, M et al. (1994) Interaction between the N-terminal domain of the 230-kDa subunit and the TATA box-binding subunit of TFIID negatively regulates TATA-box binding. Proc Natl Acad Sci U S A 91:3520-4
Martinez, E; Chiang, C M; Ge, H et al. (1994) TATA-binding protein-associated factor(s) in TFIID function through the initiator to direct basal transcription from a TATA-less class II promoter. EMBO J 13:3115-26
Martinez, E; Lagna, G; Roeder, R G (1994) Overlapping transcription by RNA polymerases II and III of the Xenopus TFIIIA gene in somatic cells. J Biol Chem 269:25692-8
Chiang, C M; Roeder, R G (1993) Expression and purification of general transcription factors by FLAG epitope-tagging and peptide elution. Pept Res 6:62-4

Showing the most recent 10 out of 60 publications